IQVIA HOLDINGS INC. Cost of Services (Deprecated 2018-01-31)
IQVIA HOLDINGS INC. (IQV) reported Cost of Services (Deprecated 2018-01-31) of $4.62 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2018-02-16
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.19B, a 7.20% increase year-over-year.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.17B, a 67.39% increase year-over-year.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $1.15B, a 57.01% increase year-over-year.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $1.11B, a 60.23% increase year-over-year.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for fiscal 2017 was $4.62B, a 42.83% increase from fiscal 2016.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for fiscal 2016 was $3.24B, a 19.63% increase from fiscal 2015.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for fiscal 2015 was $2.71B, a 1.54% increase from fiscal 2014.
- IQVIA HOLDINGS INC. cost of services (deprecated 2018-01-31) for fiscal 2014 was $2.66B, a 7.79% increase from fiscal 2013.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 3 month as first filed | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 6 month as first filed | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 9 month as first filed | Cost of Services (Deprecated 2018-01-31) 12 month | Cost of Services (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $1.19B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $2.36B derived: sum of 2 quarters · filed 2018-02-16 | $3.51B derived: sum of 3 quarters · filed 2018-02-16 | $4.62B 10-K · filed 2018-02-16 | ||||
| 2017-09-30 | $1.17B 10-Q · filed 2017-10-27 | $2.32B derived: sum of 2 quarters · filed 2017-10-27 | $3.43B 10-Q · filed 2017-10-27 | $4.54B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2017-06-30 | $1.15B 10-Q · filed 2017-08-04 | $2.27B 10-Q · filed 2017-08-04 | $3.38B derived: sum of 3 quarters · filed 2018-02-16 | $4.07B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2017-03-31 | $1.11B 10-Q · filed 2017-05-08 | $2.22B derived: sum of 2 quarters · filed 2018-02-16 | $2.92B derived: sum of 3 quarters · filed 2018-02-16 | $3.65B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-12-31 | $1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.81B derived: sum of 2 quarters · filed 2018-02-16 | $2.54B derived: sum of 3 quarters · filed 2018-02-16 | $3.24B 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | $696.00M 10-Q · filed 2017-10-27 | $703.79M 10-Q · filed 2016-11-03 | $1.43B derived: sum of 2 quarters · filed 2017-10-27 | $2.13B 10-Q · filed 2017-10-27 | $2.14B 10-Q · filed 2016-11-03 | $2.80B derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $735.00M 10-Q · filed 2017-08-04 | $740.64M 10-Q · filed 2016-07-27 | $1.43B 10-Q · filed 2017-08-04 | $1.44B 10-Q · filed 2016-07-27 | $2.11B derived: sum of 3 quarters · filed 2018-02-16 | $2.79B derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $694.00M 10-Q · filed 2017-05-08 | $700.57M 10-Q · filed 2016-05-03 | $1.37B derived: sum of 2 quarters · filed 2018-02-16 | $2.05B derived: sum of 3 quarters · filed 2018-02-16 | $2.74B derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $676.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.36B derived: sum of 2 quarters · filed 2018-02-16 | $2.04B derived: sum of 3 quarters · filed 2018-02-16 | $2.71B 10-K · filed 2018-02-16 | $2.73B 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $683.06M 10-Q · filed 2016-11-03 | $1.37B derived: sum of 2 quarters · filed 2016-11-03 | $2.03B 10-Q · filed 2016-11-03 | $2.68B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $683.85M 10-Q · filed 2016-07-27 | $1.35B 10-Q · filed 2016-07-27 | $2.00B derived: sum of 3 quarters · filed 2017-02-16 | $2.69B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $661.83M 10-Q · filed 2016-05-03 | $1.32B derived: sum of 2 quarters · filed 2017-02-16 | $2.01B derived: sum of 3 quarters · filed 2017-02-16 | $2.68B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $654.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $1.35B derived: sum of 2 quarters · filed 2017-02-16 | $2.02B derived: sum of 3 quarters · filed 2017-02-16 | $2.66B 10-K · filed 2017-02-16 | $2.68B 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $691.05M 10-Q · filed 2015-10-28 | $1.37B derived: sum of 2 quarters · filed 2015-10-28 | $2.01B 10-Q · filed 2015-10-28 | $2.65B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $674.51M 10-Q · filed 2015-07-29 | $1.32B 10-Q · filed 2015-07-29 | $1.96B derived: sum of 3 quarters · filed 2016-02-11 | $2.56B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $643.72M 10-Q · filed 2015-04-29 | $1.29B derived: sum of 2 quarters · filed 2016-02-11 | $1.89B derived: sum of 3 quarters · filed 2016-02-11 | $2.50B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $641.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $1.24B derived: sum of 2 quarters · filed 2016-02-11 | $1.86B derived: sum of 3 quarters · filed 2016-02-11 | $2.47B 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $600.69M 10-Q · filed 2014-10-30 | $1.22B derived: sum of 2 quarters · filed 2014-10-30 | $1.83B 10-Q · filed 2014-10-30 | $2.46B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $617.67M 10-Q · filed 2014-07-31 | $1.23B 10-Q · filed 2014-07-31 | $1.86B derived: sum of 3 quarters · filed 2015-02-12 | $2.47B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $611.11M 10-Q · filed 2014-05-01 | $1.24B derived: sum of 2 quarters · filed 2015-02-12 | $1.85B derived: sum of 3 quarters · filed 2015-02-12 | $2.48B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $628.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $1.24B derived: sum of 2 quarters · filed 2015-02-12 | $1.87B derived: sum of 3 quarters · filed 2015-02-12 | $2.46B 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $612.11M 10-Q · filed 2013-10-31 | $1.24B derived: sum of 2 quarters · filed 2013-10-31 | $1.83B 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $628.22M 10-Q · filed 2013-08-01 | $1.22B 10-Q · filed 2013-08-01 | ||||||
| 2011-12-31 | $2.15B 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |